Differential response of normal and transformed mammary epithelial cells to combined treatment of anti-miR-21 and radiation

References

• Anastasov N, Bonzheim I, Rudelius M, Klier M, Dau T, Angermeier D, Duyster J, Pittaluga S, Fend F, Raffeld M, et al. 2010. C/EBPbeta expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway. Haematologica. 95:760–767.
   PubMed Web of Science ®Google Scholar
• Anastasov N, Hofig I, Radulovic V, Strobel S, Salomon M, Lichtenberg J, Rothenaigner I, Hadian K, Kelm JM, Thirion C, et al. 2015. A 3D-microtissue-based phenotypic screening of radiation resistant tumor cells with synchronized chemotherapeutic treatment. BMC Cancer. 15:466.
   PubMed Web of Science ®Google Scholar
• Anastasov N, Höfig I, Vasconcellos IG, Rappl K, Braselmann H, Ludyga N, Auer G, Aubele M, Atkinson MJ. 2012. Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells. Radiat Oncol. 7:206.
   PubMed Web of Science ®Google Scholar
• Anastasov N, Klier M, Koch I, Angermeier D, Höfler H, Fend F, Quintanilla-Martinez L. 2009. Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer. J Hematopathol. 2:9–19.
   PubMedGoogle Scholar
• Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. 2008. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 27:2128–2136.
   PubMed Web of Science ®Google Scholar
• Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297.
   PubMed Web of Science ®Google Scholar
• Cellini F, Morganti AG, Genovesi D, Silvestris N, Valentini V. 2014. Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy. Molecules (Basel, Switzerland). 19:5379–5401.
   PubMed Web of Science ®Google Scholar
• Chan JA, Krichevsky AM, Kosik KS. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65:6029–6033.
   PubMed Web of Science ®Google Scholar
• Cheng CJ, Saltzman WM, Slack FJ. 2013. Canonical and non-canonical barriers facing AntimiR cancer therapeutics. CMC. 20:3582–3593.
   PubMed Web of Science ®Google Scholar
• Croce CM. 2009. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714.
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative G. 2011. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 378:1707–1716.
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. 2006. Oncomirs: microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269.
   PubMed Web of Science ®Google Scholar
• Falkenberg N, Hofig I, Rosemann M, Szumielewski J, Richter S, Schorpp K, Hadian K, Aubele M, Atkinson MJ, Anastasov N. 2016. Three-dimensional microtissues essentially contribute to preclinical validations of therapeutic targets in breast cancer. Cancer Med. 5:703–710.
   PubMed Web of Science ®Google Scholar
• Folini M, Gandellini P, Longoni N, Profumo V, Callari M, Pennati M, Colecchia M, Supino R, Veneroni S, Salvioni R, et al. 2010. miR-21: an oncomir on strike in prostate cancer. Mol Cancer. 9:12.
   PubMed Web of Science ®Google Scholar
• Glaysher S, Bolton LM, Johnson P, Torrance C, Cree IA. 2014. Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model. BMC Res Notes. 7:397.
   PubMedGoogle Scholar
• Gong C, Yao Y, Wang Y, Liu B, Wu W, Chen J, Su F, Yao H, Song E. 2011. Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem. 286:19127–19137.
   PubMed Web of Science ®Google Scholar
• Gwak HS, Kim TH, Jo GH, Kim YJ, Kwak HJ, Kim JH, Yin J, Yoo H, Lee SH, Park JB. 2012. Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines. PLoS One. 7:e47449.
   PubMed Web of Science ®Google Scholar
• Hill RP, Rodemann HP, Hendry JH, Roberts SA, Anscher MS. 2001. Normal tissue radiobiology: from the laboratory to the clinic. Int J Radiat Oncol Biol Phys. 49:353–365.
   PubMed Web of Science ®Google Scholar
• Hofig I, Atkinson MJ, Mall S, Krackhardt AM, Thirion C, Anastasov N. 2012. Poloxamer synperonic F108 improves cellular transduction with lentiviral vectors. J Gene Med. 14:549–560.
   PubMed Web of Science ®Google Scholar
• Kasinski AL, Slack FJ. 2011. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 11:849–864.
   PubMed Web of Science ®Google Scholar
• Krichevsky AM, Gabriely G. 2009. miR-21: a small multi-faceted RNA. J Cell Mol Med. 13:39–53.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhu H, Yang X, Ge Y, Zhang C, Qin Q, Lu J, Zhan L, Cheng H, Sun X. 2014. MicroRNA-21 is a novel promising target in cancer radiation therapy. Tumor Biol. 35:3975–3979.
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al. 2005. MicroRNA expression profiles classify human cancers. Nature. 435:824–838.
   PubMed Web of Science ®Google Scholar
• Ma Y, Xia H, Liu Y, Li M. 2014. Silencing miR-21 sensitizes non-small cell lung cancer A549 cells to ionizing radiation through inhibition of PI3K/Akt. BioMed Res Int. 2014:617868.
   PubMed Web of Science ®Google Scholar
• McManus MT. 2003. MicroRNAs and cancer. Semin Cancer Biol. 13:253–258.
   PubMed Web of Science ®Google Scholar
• Medina PP, Nolde M, Slack FJ. 2010. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature. 467:86–90.
   PubMed Web of Science ®Google Scholar
• Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. 2007. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 133:647–658.
   PubMed Web of Science ®Google Scholar
• Najafi Z, Sharifi M, Javadi G. 2015. Degradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma. Cancer Gene Ther. 22:530–535.
   PubMed Web of Science ®Google Scholar
• Nusse M, Beisker W, Kramer J, Miller BM, Schreiber GA, Viaggi S, Weller EM, Wessels JM. 1994. Measurement of micronuclei by flow cytometry. Methods Cell Biol. 42 Pt B:149–158.
   PubMed Web of Science ®Google Scholar
• Poltronieri P, D’Urso PI, Mezzolla V, D’Urso OF. 2013. Potential of anti-cancer therapy based on anti-miR-155 oligonucleotides in glioma and brain tumours. Chem Biol Drug Des. 81:79–84.
   PubMed Web of Science ®Google Scholar
• Price C, Chen J. 2014. MicroRNAs in cancer biology and therapy: current status and perspectives. Genes Dis. 1:53–63.
   PubMedGoogle Scholar
• Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K, et al. 2005. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 97:116–126.
   PubMedGoogle Scholar
• Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S, Cole CN. 2007. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res. 67:11612–11620.
   PubMed Web of Science ®Google Scholar
• Sharma SV, Settleman J. 2007. Oncogene addiction: setting the stage for molecularly targeted cancer therapy. Genes Develop. 21:3214–3231.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zhang X, Tang X, Wang P, Wang H, Wang Y. 2012. MiR-21 is continually elevated long-term in the brain after exposure to ionizing radiation. Radiat Res. 177:124–128.
   PubMed Web of Science ®Google Scholar
• Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. 2007. miR-21-mediated tumor growth. Oncogene. 26:2799–2803.
   PubMed Web of Science ®Google Scholar
• Sicard F, Gayral M, Lulka H, Buscail L, Cordelier P. 2013. Targeting miR-21 for the therapy of pancreatic cancer. Mol Ther. 21:986–994.
   PubMed Web of Science ®Google Scholar
• Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50:6075–6086.
   PubMed Web of Science ®Google Scholar
• Summerer I, Unger K, Braselmann H, Schuettrumpf L, Maihoefer C, Baumeister P, Kirchner T, Niyazi M, Sage E, Specht HM, et al. 2015. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients. Br J Cancer. 113:76–82.
   PubMed Web of Science ®Google Scholar
• Tinoco G, Warsch S, Gluck S, Avancha K, Montero AJ. 2013. Treating breast cancer in the 21st century: emerging biological therapies. J Cancer. 4:117–132.
   PubMed Web of Science ®Google Scholar
• Wang P, Zou F, Zhang X, Li H, Dulak A, Tomko RJ Jr, Lazo JS, Wang Z, Zhang L, Yu J. 2009. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res. 69:8157–8165.
   PubMed Web of Science ®Google Scholar
• Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ, Hou JH, Fu J, Zeng MS, Yun JP, Wu QL, et al. 2011. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res. 13:R2.
   PubMed Web of Science ®Google Scholar
• Yang CH, Yue J, Pfeffer SR, Fan M, Paulus E, Hosni-Ahmed A, Sims M, Qayyum S, Davidoff AM, Handorf CR, et al. 2014. MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3). J Biol Chem. 289:25079–25087.
   PubMed Web of Science ®Google Scholar
• Zhang ZJ, Ma SL. 2012. miRNAs in breast cancer tumorigenesis (Review). Oncol Rep. 27:903–910.
   PubMed Web of Science ®Google Scholar